Article

Health Advocate Amy Byer Shainman Discusses Risk Management of Hereditary Cancers

When it comes to managing your risk of cancer, especially when dealing with a familial cancer risk, "what is right for one person, may not be right for another," says Amy Byer Shainman.

When it comes to managing your risk of cancer, especially when dealing with a familial cancer risk, "what is right for one person, may not be right for another," says Amy Byer Shainman.

Shainman had preventive surgeries after she found she was at high risk for breast and ovarian cancers due to a BRCA mutation. Several family members had been diagnosed with cancer, which led her to meet with a genetic counselor and receive genetic testing. She is now a health advocate for those at risk of hereditary-associated cancers and blogs at http://thebrcaresponder.blogspot.com.

"Get the education; what are your individual risks? What do they mean?" she advises. In addition to genetic counseling, weigh all your options, she suggsts, including possible chemoprevention, increased screening or preventive surgery.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of Dr. Boffa.
Immune Therapy Expands Melanoma Treatment to More Patients
Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment plan.
image of doctor D'Sa
Image of Dr. Eng.
Image of Dr. Tagawa.
Most patients in accredited hospitals had smoking discussions documented, showing key care opportunities and smoking’s impact on treatment outcomes.
Illustration of doctor.
Image of doctor.
Image of man with black hair.
Related Content
Image of ovary.
May 8th 2025

The OVATION 3 Study Initiates First Trial Site for Ovarian Cancer

Ryan Scott
The first trial site has been initiated in the pivotal phase 3 OVATION 3 study which will investigate IMNN-001 for newly diagnosed advanced ovarian cancer.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.
May 7th 2025

Managing Lung Inflammation After Chemoradiation and Tagrisso

Dr. Suresh S. Ramalingam
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Image of two woman with ribbons.
May 7th 2025

Breast Cancer Survivor Reflects on 30 Years, Urges Informed Decisions

Connie Pombo
After 30 years with breast cancer, I urge others to pause, reflect and choose care based on long-term wellbeing, not fear or pressure.
Kelly Irvin was diagnosed with stage 4 ovarian cancer in January 2016. Catch up on all of Kelly's blogs here!
May 6th 2025

Nurse’s Big Personality Makes Cancer Treatment More Bearable.

Kelly Irvin
She wore a variety of bright sneakers and occasionally did a cha-cha-cha in them. Her laughter was contagious. Patients smiled. The other nurses smiled.